Table of Contents

company-logo

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin A nephropathy. The company's lead product candidate is Setanaxib, a NOX inhibitor that is in Phase 2b/3 clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for type 1 diabetic kidney disease. It also develops Budenofalk 3 mg oral capsules for the treatment of autoimmune hepatitis. The company was incorporated in 2004 and is headquartered in Stockholm, Sweden.

Calliditas Therapeutics Dividend Announcement

• Calliditas Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Calliditas Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Calliditas Therapeutics Dividend History

Calliditas Therapeutics Dividend Yield

Calliditas Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Calliditas Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Calliditas Therapeutics Financial Ratios

P/E ratio-49.40
PEG ratio0.10
P/B ratio222.22
ROE-210.18%
Payout ratio0.00%
Current ratio2.69
Quick ratio2.59
Cash Ratio1.86

Calliditas Therapeutics Dividend FAQ

Does Calliditas Therapeutics stock pay dividends?
Calliditas Therapeutics does not currently pay dividends to its shareholders.
Has Calliditas Therapeutics ever paid a dividend?
No, Calliditas Therapeutics has no a history of paying dividends to its shareholders. Calliditas Therapeutics is not known for its dividend payments.
Why doesn't Calliditas Therapeutics pay dividends?
There are several potential reasons why Calliditas Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Calliditas Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Calliditas Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Calliditas Therapeutics a dividend aristocrat?
Calliditas Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Calliditas Therapeutics a dividend king?
Calliditas Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Calliditas Therapeutics a dividend stock?
No, Calliditas Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Calliditas Therapeutics stocks?
To buy Calliditas Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Calliditas Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.